Please Wait
Applying Filters...
menu
    • menu
    Top news of 2025: Drugmakers invest in US capacities, agree to lower Medicaid prices; Pfizer buys obesity-focused biotech Metsera

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    N-(2-Nitrooxy-ethyl)-nicotinamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 424Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    30/12/2025 Vital Laboratories Private Limited
    India
    		 Bansen Co., Ltd. 20250307-209-J-1723 Nikorandil 2025-03-07 Vital Laboratories Pvt. Ltd. India Plot No. 1710 Phase-Ⅲ, GIDC Estate, Vapi - 396 195 vALSAD, Gujarat State, India
    30/12/2025 Anek Prayog Pvt. Ltd.,
    India
    		 Kukjeon Pharmaceutical Co., Ltd. 20190108-209-J-178 Nikorandil 2019-01-08 Anek Prayog Pvt Ltd India 57/2, 119, MIDC IND Area Dhatav-Roha, District-Raigad-402 116 Maharashtra
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.